STOCK TITAN

United States Antimony Corporation 10-Q Filings

UAMY NYSE

Every 10-Q that United States Antimony Corporation (UAMY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow UAMY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UAMY filings page.

Rhea-AI Summary

United States Antimony Corporation reported lower sales and a swing to loss while significantly strengthening its balance sheet and advancing growth projects for the six months ended June 30, 2026. Revenue was $14,709,670, down from $17,525,128 a year earlier, with antimony sales declining and zeolite sales increasing. Cost inflation and sharply higher operating expenses, including $7,738,892 of share-based compensation, drove an operating loss of $14,498,095 versus prior-year operating income of $377,999. The company recorded a net loss of $11,184,200 compared with net income of $728,079 in 2025.

Liquidity improved through equity issuance and a federal grant. Cash and cash equivalents were $41,434,379 and total assets $190,616,714, while debt remained low at $334,775. An at-the-market stock program raised $49,070,838 net, and a $27.0 million Defense Production Act grant is funding expansion of the Thompson Falls, Montana facility, of which $12,848,246 has been recognized as a reduction of property, plant and equipment. The smelter expansion, with total estimated capital of about $39 million, was substantially completed in the quarter. The company also holds a $43,219,151 equity stake in Larvotto Resources Limited, generating significant unrealized gains, and secured a five-year IDIQ contract with the U.S. Defense Logistics Agency with a maximum value of $245 million, with initial shipments of approximately 82,000 pounds of antimony to be recognized as $2.6 million of third-quarter revenue.

Rhea-AI Summary

United States Antimony Corporation reported a net loss of $11.3M for the quarter ended March 31, 2026, compared with net income in the prior-year period. Revenue edged down to $6.8M, but gross profit fell sharply as costs per pound of antimony and per ton of zeolite rose and inventory was written down to net realizable value.

Operating expenses increased to $8.6M, driven largely by $4.8M of share-based compensation, while an unrealized loss of $4.1M on the Larvotto equity investment pushed total other expense to $3.8M. Cash and equivalents declined to $3.4M from $30.7M as the company used $12.1M in operating cash flow and $12.6M for capital expenditures, including a precious metals mill acquisition and expansion of the Thompson Falls facility.

In March 2026, the company was awarded a $27.0M Defense Production Act grant to expand and modernize U.S. antimony processing, with $12.8M of milestone funding recognized as a government grant receivable and recorded as a reduction of construction-in-progress assets. Subsequent to quarter-end, US Antimony raised additional equity through “at-the-market” offerings totaling $48.6M, supporting its aggressive capital program and new hydrometallurgical joint venture development.

Rhea-AI Summary

United States Antimony Corporation reported sharply higher sales and larger losses in its Q3 results. Revenue rose to $8,701,951 from $2,572,178 a year ago, driven by antimony products, while gross profit reached $2,013,442. The company posted a net loss of $4,780,700 as operating expenses jumped, including non‑cash share‑based compensation.

Year to date, revenue was $26,227,079. The balance sheet strengthened with cash and cash equivalents of $18,338,679 and held‑to‑maturity U.S. Treasury Strips at $20,157,393 amortized cost. Operating cash flow was $(6,220,686), offset by $42,415,350 provided by financing activities, including an at‑the‑market sale and a registered direct offering; warrant exercises added cash as well.

The company disclosed a five‑year IDIQ contract with the DLA Strategic Materials for antimony metal ingots, with a maximum value of $245 million through September 2030. An initial delivery order for 315,000 pounds is valued at approximately $10 million; no revenue has been recognized yet. Inventory increased to $8,413,161, PP&E to $28,121,338, and management booked a $469,822 gain on early termination of a Montana lease.

Rhea-AI Summary

United States Antimony Corporation (UAMY) reported strong year-over-year revenue growth driven by antimony price gains: second-quarter revenue rose to $10,525,123 from $3,662,977 a year earlier and six-month revenue reached $17,525,128 versus $6,735,044. Antimony prices per pound increased sharply (quarterly average $28.32 versus $6.96), which more than offset lower sales volumes and expanded gross profit to $2,837,545 for the quarter and $5,209,275 year-to-date. The company recorded net income of $181,555 for the quarter and $728,079 for the six months.

Balance sheet and cash flow changes reflect an investment and expansion phase: total assets grew to $47,498,322 from $34,642,602, property, plant and equipment rose to $19,725,995, inventories increased to $6,812,527, and the company purchased $9,991,259 of U.S. Treasury Strips. Cash and cash equivalents declined to $5,708,660 from $18,172,120, largely from $17,384,832 used in investing activities including a $5,000,000 acquisition of Ontario mining claims (Fostung Properties) and ongoing claim acquisition commitments. The company also raised capital through stock sales and warrant exercises totaling over $7 million net proceeds year-to-date.